Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial HypercholesterolemiaCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32025-03-010OAAI
A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPDSCIENTIFIC REPORTSIF3.92023-05-221OAAI
Identification of a unique temporal signature in blood and BAL associated with IPF progressionSCIENTIFIC REPORTSIF3.92020-07-2111OAAI
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary FibrosisAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42019-05-01225OAAI
Lung Dysbiosis, Inflammation, and Injury in Hematopoietic Cell TransplantationAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42018-11-1541OAAI
Proteomics: Clinical and research applications in respiratory diseases蛋白质组学: 在呼吸系统疾病中的临床和研究应用RESPIROLOGYIF6.32018-08-1319OAAI
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes (vol 7, 46560, 2017)SCIENTIFIC REPORTSIF3.92017-06-300OAAI
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processesSCIENTIFIC REPORTSIF3.92017-04-2548OAAI